National Vaccine Advisory Committee, 62479-62480 [E7-21682]

Download as PDF Federal Register / Vol. 72, No. 213 / Monday, November 5, 2007 / Notices ycherry on PRODPC74 with NOTICES If and when your debarment becomes effective, you will be prohibited from participating in activities associated with or related to the schools and libraries support mechanism for three years from the date of debarment.19 The Bureau may, if necessary to protect the public interest, extend the debarment period.20 Please direct any response, if by messenger or hand delivery, to Marlene H. Dortch, Secretary, Federal Communications Commission, 236 Massachusetts Avenue, NE., Suite 110, Washington, DC 20002, to the attention of Diana Lee, Attorney Advisor, Investigations and Hearings Division, Enforcement Bureau, Room 4–C330, with a copy to Vickie Robinson, Assistant Chief, Investigations and Hearings Division, Enforcement Bureau, Room 4–C330, Federal Communications Commission. If sent by commercial overnight mail (other than U.S. Postal Service Express Mail and Priority Mail), the response should be sent to the Federal Communications Commission, 9300 East Hampton Drive, Capitol Heights, Maryland 20743. If sent by first-class, Express, or Priority mail, the response should be sent to Diana Lee, Attorney Advisor, Investigations and Hearings Division, Enforcement Bureau, Federal Communications Commission, 445 12th Street, SW., Room 4–C330, Washington, DC 20554, with a copy to Vickie Robinson, Assistant Chief, Investigations and Hearings Division, Enforcement Bureau, Federal Communications Commission, 445 12th Street, SW., Room 4–C330, Washington, DC 20554. You shall also transmit a copy of the response via e-mail to diana.lee@fcc.gov and to vickie.robinson@fcc.gov. If you have any questions, please contact Ms. Lee via mail, by telephone at (202) 418–1420 or by e-mail at diana.lee@fcc.gov. If Ms. Lee is unavailable, you may contact Ms. Vickie Robinson, Assistant Chief, Investigations and Hearings Division, by telephone at (202) 418–1420 and by email at vickie.robinson@fcc.gov. Sincerely yours, Hillary S. DeNigro Chief, Investigations and Hearings Division Enforcement Bureau cc: Kristy Carroll, Esq., Universal Service Administrative Company a finding of extraordinary circumstances, following the filing of a petition by you or an interested party or upon motion by the Commission. 47 CFR 54.521(f). 19 Second Report and Order, 18 FCC Rcd at 9225, ¶ 67; 47 CFR 54.521(d), 54.521(g). 20 Id. VerDate Aug<31>2005 15:04 Nov 02, 2007 Jkt 214001 (via e-mail) Aaron M. Danzig, Esq., Assistant United States Attorney [FR Doc. E7–21719 Filed 11–2–07; 8:45 am] BILLING CODE 6712–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: Authority: 42 U.S.C. 300aa–5, Section 2105 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The National Vaccine Program Office (NVPO), a program office within the Office of Public Health and Science, DHHS, is soliciting nominations of qualified candidates to be considered for appointment as members to the National Vaccine Advisory Committee (NVAC). The activities of this Committee are governed by the Federal Advisory Committee Act (FACA). Consistent with the National Vaccine Plan, the Committee advises and makes recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the Committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The Committee also advises the Assistant Secretary for Health in the implementation of Sections 2102 and 2103 of the PHS Act; and identifies annually the most important areas of government and non-government cooperation that should be considered in implementing Sections 2102 and 2103 of the PHS Act. DATES: Nominations for membership on the Committee must be received no later than 5 p.m. EST on December 11, 2007, at the address below. ADDRESSES: All nominations should be mailed or delivered to: Bruce G. Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of Public Health and Science, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 62479 Humphrey Building; Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. Humphrey Building, Washington, DC 20201; (202) 690–5566; nvpo@hhs.gov. A copy of the Committee charter and list of the current membership can be obtained by contacting Ms. English or by accessing the NVAC Web site at: https://www.hhs.gov/nvpo/nvac. SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and Information Required: As part of an ongoing effort to enhance deliberations and discussions with the public on vaccine and immunization policy, nominations are being sought for interested individuals to serve on the Committee. Individuals selected for appointment to the Committee will serve as voting members. Voting members shall be selected from individuals who are engaged in vaccine research or the manufacture of vaccines, or who are physicians, members of parent organizations concerned with immunizations, representatives of state or local health agencies or public health organizations. The Committee currently has particular needs for individuals with expertise in the fields of vaccine safety and vaccine and immunization financing. Individuals selected for appointment to the Committee can be invited to serve terms of up to four years. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee; (2) the nominator’s name, address and daytime telephone number, and the home and/ or work address, telephone number, and email address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Applications cannot be submitted by facsimile. The names of Federal employees should not be nominated for consideration of appointment to this Committee. The Department makes every effort to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view E:\FR\FM\05NON1.SGM 05NON1 62480 Federal Register / Vol. 72, No. 213 / Monday, November 5, 2007 / Notices represented and the committee’s function. Every effort is made that a broad representation of geographic areas, gender, ethnic and minority groups, and the disabled are given consideration for membership on HHS Federal advisory committees. Appointment to this committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. The Standards of Ethical Conduct for Employees of the Executive Branch are applicable to individuals who are appointed as public members of Federal advisory committees. Individuals appointed to serve as public members of Federal advisory committees are classified as special Government employees (SGEs). SGEs are Government employees for purposes of the conflict of interest laws. Therefore, individuals appointed to serve as public members of NVAC are subject to an ethics review. The ethics review is conducted to determine if the individual has any interests and/or activities in the private sector that may conflict with performance of their official duties as a member of the Committee. Individuals appointed to serve as public members of the Committee will be required to disclose information regarding financial holdings, consultancies, and research grants and/or contracts. Dated: October 30, 2007. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. E7–21682 Filed 11–2–07; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–08–07AL] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 404–639–5960 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC, or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Notice of Correction to Burden Table Proposed Project Evaluation of the Successful Business Strategies to Prevent Heart Disease and Stroke Toolkit—NEW—Division for Heart Disease and Stroke Prevention (DHDSP), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Description of Correction The previous 30-day Federal Register Notice (FRN) published August 31, 2007, Volume 72, No. 169, Pages 50371– 50372, was submitted with an error showing the number of respondents as 51. This correction reduces the number of respondents from 51 to 25. Background and Brief Description Under Part C (Centers for Disease Control and Prevention) of the Statement of Organization Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 72842–72843, dated December 7, 2005), the Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention was established. This Division plans, directs, and coordinates programs to reduce morbidity, risk factors, costs, disability, mortality, and disparities associated with heart disease, stroke, and other cardiovascular disease outcomes. Under this Division, formative research was conducted to identify effective interventions and promising practices for preventing heart disease and stroke at the work site. In 2005, this research resulted in the development of a Successful Business Strategies to Prevent Heart Disease and Stroke Toolkit. The toolkit provides state programs with suggestions about which health benefits, services, and interventions can improve employee cardiovascular health, prevent heart disease and stroke, and reduce related costs. The second phase of this project focuses on disseminating and evaluating the Successful Business Strategies to Prevent Heart Disease and Stroke Toolkit. As part of the Toolkit evaluation, the CDC has employed contractor support to design and conduct a Web-based survey of State Health Departments to gather information on their experiences with the Toolkit. The contractor will collect and analyze all data from this survey. The CDC has also contracted to make revisions to the toolkit based on results of this survey, ongoing feedback from the States, and feedback from employers through interviews. The Centers for Disease Control and Prevention (CDC) is seeking a 6-month Office of Management and Budget (OMB) approval for implementing the Webbased survey. There are no costs to respondents except for their time to complete the survey. The total estimated annualized burden hours are 13. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name State Heart Disease and Stroke Programs .... ycherry on PRODPC74 with NOTICES Type of respondents Web-based survey on CVH Toolkit ............... VerDate Aug<31>2005 17:17 Nov 02, 2007 Jkt 214001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM Number of responses per respondent 25 05NON1 1 Average burden per response (in hrs.) 30/60

Agencies

[Federal Register Volume 72, Number 213 (Monday, November 5, 2007)]
[Notices]
[Pages 62479-62480]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21682]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of Public Health and Science, DHHS, is soliciting 
nominations of qualified candidates to be considered for appointment as 
members to the National Vaccine Advisory Committee (NVAC). The 
activities of this Committee are governed by the Federal Advisory 
Committee Act (FACA).
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on 
matters related to the Program's responsibilities. Specifically, the 
Committee studies and recommends ways to encourage the availability of 
an adequate supply of safe and effective vaccination products in the 
United States; recommends research priorities and other measures to 
enhance the safety and efficacy of vaccines. The Committee also advises 
the Assistant Secretary for Health in the implementation of Sections 
2102 and 2103 of the PHS Act; and identifies annually the most 
important areas of government and non-government cooperation that 
should be considered in implementing Sections 2102 and 2103 of the PHS 
Act.

DATES: Nominations for membership on the Committee must be received no 
later than 5 p.m. EST on December 11, 2007, at the address below.

ADDRESSES: All nominations should be mailed or delivered to: Bruce G. 
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of Public 
Health and Science, Department of Health and Human Services, 200 
Independence Avenue, SW., Room 443-H, Hubert H. Humphrey Building; 
Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. Humphrey 
Building, Washington, DC 20201; (202) 690-5566; nvpo@hhs.gov.
    A copy of the Committee charter and list of the current membership 
can be obtained by contacting Ms. English or by accessing the NVAC Web 
site at: https://www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION:
    Committee Function, Qualifications, and Information Required: As 
part of an ongoing effort to enhance deliberations and discussions with 
the public on vaccine and immunization policy, nominations are being 
sought for interested individuals to serve on the Committee. 
Individuals selected for appointment to the Committee will serve as 
voting members. Voting members shall be selected from individuals who 
are engaged in vaccine research or the manufacture of vaccines, or who 
are physicians, members of parent organizations concerned with 
immunizations, representatives of state or local health agencies or 
public health organizations. The Committee currently has particular 
needs for individuals with expertise in the fields of vaccine safety 
and vaccine and immunization financing. Individuals selected for 
appointment to the Committee can be invited to serve terms of up to 
four years.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee; (2) the nominator's name, 
address and daytime telephone number, and the home and/or work address, 
telephone number, and email address of the individual being nominated; 
and (3) a current copy of the nominee's curriculum vitae. Applications 
cannot be submitted by facsimile. The names of Federal employees should 
not be nominated for consideration of appointment to this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view

[[Page 62480]]

represented and the committee's function. Every effort is made that a 
broad representation of geographic areas, gender, ethnic and minority 
groups, and the disabled are given consideration for membership on HHS 
Federal advisory committees. Appointment to this committee shall be 
made without discrimination on the basis of age, race, ethnicity, 
gender, sexual orientation, disability, and cultural, religious, or 
socioeconomic status.
    The Standards of Ethical Conduct for Employees of the Executive 
Branch are applicable to individuals who are appointed as public 
members of Federal advisory committees. Individuals appointed to serve 
as public members of Federal advisory committees are classified as 
special Government employees (SGEs). SGEs are Government employees for 
purposes of the conflict of interest laws. Therefore, individuals 
appointed to serve as public members of NVAC are subject to an ethics 
review. The ethics review is conducted to determine if the individual 
has any interests and/or activities in the private sector that may 
conflict with performance of their official duties as a member of the 
Committee. Individuals appointed to serve as public members of the 
Committee will be required to disclose information regarding financial 
holdings, consultancies, and research grants and/or contracts.

    Dated: October 30, 2007.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. E7-21682 Filed 11-2-07; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.